Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00065104 · ClinicalTrials.gov registry record · Phase 2
Dehydroepiandrosterone Effects on HIV-1 Replication
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT00065104 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 40 participants.
The verdict
NCT00065104, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study's purpose is to learn how dehydroepiandrosterone (DHEA) affects the HIV virus, the immune system, hormone levels, body composition and quality of life.
Interventions
- DRUG DHEA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2000-10 |
| Est. Completion | 2003-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00065104
The ClinicalTrials.gov registry entry for NCT00065104 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DHEA is the first listed.
NCT00065104 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00065104 about?
NCT00065104 is a clinical study titled "Dehydroepiandrosterone Effects on HIV-1 Replication". This study's purpose is to learn how dehydroepiandrosterone (DHEA) affects the HIV virus, the immune system, hormone levels, body composition and quality of life.
What is the current status of trial NCT00065104?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2000-10. Estimated completion is 2003-04.
What interventions are being tested in trial NCT00065104?
The interventions under investigation include: DHEA (DRUG).
Who is sponsoring clinical trial NCT00065104?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.